NewCardio Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. NewCardio last-minute Real Value cannot be determined due to lack of data. The latest price of NewCardio is $0.0. Our model forecasts the value of NewCardio from analyzing the firm fundamentals such as Return On Asset of -2.24, price to sales of 0.21 X, and Current Valuation of 49.72 K as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting NewCardio's valuation include:
Enterprise Value
49.7 K
Enterprise Value Ebitda
(0.01)
Price Sales
0.2084
Enterprise Value Revenue
0.2084
Undervalued
Today
0.00
Please note that NewCardio's price fluctuation is out of control at this time. Calculation of the real value of NewCardio is based on 3 months time horizon. Increasing NewCardio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since NewCardio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NewCardio Stock. However, NewCardio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0 Real  0.0 Hype  0.0
The intrinsic value of NewCardio's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence NewCardio's stock price.
0.00
Real Value
0.00
Upside
Estimating the potential upside or downside of NewCardio helps investors to forecast how NewCardio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NewCardio more accurately as focusing exclusively on NewCardio's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
When choosing an evaluation method for NewCardio, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.

NewCardio Cash

500,153

NewCardio Valuation Trend

NewCardio's real value analysis enables investors to forecast the earnings more efficiently. Using both NewCardio's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.

NewCardio Total Value Analysis

NewCardio is now forecasted to have valuation of 49.72 K with market capitalization of 49.72 K, debt of 6.01 M, and cash on hands of 13.06 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NewCardio fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
49.72 K
49.72 K
6.01 M
13.06 K

NewCardio Investor Information

The company had not issued any dividends in recent years. Based on the analysis of NewCardio's profitability, liquidity, and operating efficiency, NewCardio may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

NewCardio Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NewCardio has an asset utilization ratio of 9.02 percent. This signifies that the Company is making $0.0902 for each dollar of assets. An increasing asset utilization means that NewCardio is more efficient with each dollar of assets it utilizes for everyday operations.
 
Credit Downgrade
 
Yuan Drop
 
Covid

NewCardio Profitability Analysis

The company reported the previous year's revenue of 257.4 K. Net Loss for the year was (11.5 M) with profit before overhead, payroll, taxes, and interest of 70.81 K.

About NewCardio Valuation

An absolute valuation paradigm, as applied to NewCardio Stock, attempts to find the value of NewCardio based on its fundamental and basic technical indicators. By analyzing NewCardio's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of NewCardio's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of NewCardio. We calculate exposure to NewCardio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NewCardio's related companies.
Last ReportedProjected for Next Year
Gross Profit120.9 K126.9 K
Pretax Profit Margin(39.46)(41.43)
Operating Profit Margin(42.26)(40.15)
Net Loss(51.36)(48.79)
Gross Profit Margin 0.37  0.28 

NewCardio Current Valuation Indicators

Valuation refers to the process of determining the present value of NewCardio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NewCardio we look at many different elements of the entity such as NewCardio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NewCardio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NewCardio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NewCardio's worth.

Complementary Tools for NewCardio Stock analysis

When running NewCardio's price analysis, check to measure NewCardio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewCardio is operating at the current time. Most of NewCardio's value examination focuses on studying past and present price action to predict the probability of NewCardio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewCardio's price. Additionally, you may evaluate how the addition of NewCardio to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges